Synopsis: KRM Ayurveda Limited reported FY26 revenue of Rs. 101.69 crore and net profit of Rs. 20.12 crore, reflecting strong growth of 33 percent YoY in revenue and 79 percent YoY in profitability. The company also delivered a sharp improvement in the latest half-year, with profit rising 149 percent YoY, supported by strong demand and operating leverage.
KRM Ayurveda has a total market capitalization of Rs. 538.11 crore, according to data on the NSE. The stock was listed on the exchanges on January 29, 2026. KRM Ayurveda shares were trading at Rs. 254.95 apiece on the National Stock Exchange; the stock has gone up around 17.90 percent over the last five sessions, while it has surged about 38.92 percent in the 30 days. Over a six-month period, the stock has given a return of 49.33 percent, whereas on a year-on-year basis it has surged nearly 49.91 percent, reflecting exceptional overall performance. The stock’s 52-week high was Rs. 263.50 and 52-week low was Rs. 156.15.
KRM Ayurveda Limited reported a strong set of results for the period ended March 31, 2026, showing robust growth on both a half-year and yearly basis. The company posted revenue from operations of Rs. 53.33 crore for the half year ended March 2026, compared to Rs. 40.84 crore in the same period last year, registering a growth of around 30.6 percent. On a full-year basis, revenue increased to Rs. 101.69 crore from Rs. 76.55 crore, reflecting a strong growth of approximately 32.8 percent, indicating rising demand across its ayurvedic and wellness product portfolio.
On the profitability front, the company delivered strong growth, reporting a net profit of Rs. 11.90 crore in the latest half year compared to Rs. 4.78 crore in the corresponding period last year, marking a sharp growth of around 149 percent. On a full-year basis, net profit stood at Rs. 20.12 crore compared to Rs. 11.21 crore in FY25, reflecting a growth of approximately 79.5 percent, highlighting strong margin expansion and improved operational efficiency.
Margins improved significantly during the period, supported by strong operating leverage and efficient cost management. Total expenses stood at Rs. 37.94 crore in the latest half year, compared to Rs. 34.76 crore in the same period last year, reflecting an increase of around 9.2 percent, which is much lower than revenue growth. On a yearly basis, expenses increased to Rs. 75.59 crore from Rs. 61.75 crore, reflecting a rise of approximately 22.4 percent, again lower than revenue growth, leading to margin expansion.
A key driver of profitability was strong cost control and scale benefits. While employee benefit expenses increased to Rs. 11.03 crore from Rs. 10.10 crore and other expenses rose to Rs. 18.59 crore from Rs. 16.91 crore, the overall cost growth remained well below revenue growth. Additionally, finance costs declined from Rs. 1.80 crore to Rs. 1.54 crore, supporting profitability. This indicates improved financial efficiency and lower leverage impact.
At the operating level, profit before tax stood at Rs. 15.72 crore in the latest half year, compared to Rs. 6.47 crore in the same period last year, reflecting a sharp growth of around 143 percent. On a full-year basis, PBT increased to Rs. 26.73 crore from Rs. 15.20 crore, indicating a growth of approximately 75.8 percent, highlighting strong core business performance.
Earnings per share (EPS) for the period stood at Rs. 5.60 in the latest half year compared to Rs. 319 in the previous year period. However, it is important to note that the company had 1,55,20,800 shares earlier and after the recent IPO, it issued an additional 57,40,000 shares, taking the total to 2,12,60,800 shares. If this higher share base had been considered in FY25, the EPS would have been approximately Rs. 2.25, indicating that the earlier EPS appears higher due to a lower equity base.
From an industry perspective, the ayurveda and wellness sector is witnessing strong structural growth driven by increasing health awareness, preference for natural and herbal products and rising demand for preventive healthcare. The post-pandemic shift toward immunity-boosting and organic products has further accelerated growth in this segment. Companies with strong branding, distribution networks and product diversification like KRM Ayurveda are well positioned to benefit from these trends.
The sharp improvement in profitability can be attributed to a combination of strong revenue growth (33 percent YoY), controlled expense growth (22 percent YoY) and lower finance costs, leading to significant operating leverage. This means that incremental revenue is translating efficiently into higher profits, resulting in margin expansion.
Overall, the FY26 results indicate that KRM Ayurveda is in a strong growth phase, supported by favorable industry tailwinds, rising demand and efficient cost management. The company has demonstrated its ability to scale profitably while improving margins. Going forward, the company’s performance will depend on sustaining demand momentum, expanding product offerings and maintaining cost discipline in a competitive wellness market.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
